NSC 702827; Orantinib; TSU-68
Cell-permeable. A potent and ATP-competitive inhibitor of PDGF, VEGF and FGF receptor tyrosine kinases (RTKs) with ICvalues of 0.06, 2.43, 3.04 and 100M at PDGFR, VEGFR2. FGFR1 and EGFR respectively. Acts as a potent antiangiogenic and antitumor agent.
Research or further manufacturing use only, not for food or drug use.